| 000 | 01853 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517174501.0 | ||
| 264 | 0 | _c20180612 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2017.08.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoozbehkia, Maryam | |
| 245 | 0 | 0 |
_aThe potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cNov 2017 |
||
| 300 |
_a191-196 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHexuronic Acids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 14 _xgenetics |
| 650 | 0 | 4 |
_aMyeloid Differentiation Factor 88 _xgenetics |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 |
_aToll-Like Receptor 2 _xmetabolism |
| 650 | 0 | 4 |
_aToll-Like Receptor 4 _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMahmoudi, Mahdi | |
| 700 | 1 | _aAletaha, Somaye | |
| 700 | 1 | _aRezaei, Nima | |
| 700 | 1 | _aFattahi, Mohammad Javad | |
| 700 | 1 | _aJafarnezhad-Ansariha, Fahimeh | |
| 700 | 1 | _aBarati, Anis | |
| 700 | 1 | _aMirshafiey, Abbas | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 52 _gp. 191-196 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2017.08.018 _zAvailable from publisher's website |
| 999 |
_c27592504 _d27592504 |
||